These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 18273839)
1. Unclassified variants identified in BRCA1 exon 11: Consequences on splicing. Anczuków O; Buisson M; Salles MJ; Triboulet S; Longy M; Lidereau R; Sinilnikova OM; Mazoyer S Genes Chromosomes Cancer; 2008 May; 47(5):418-26. PubMed ID: 18273839 [TBL] [Abstract][Full Text] [Related]
2. RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain. Campos B; Díez O; Domènech M; Baena M; Balmaña J; Sanz J; Ramírez A; Alonso C; Baiget M Hum Mutat; 2003 Oct; 22(4):337. PubMed ID: 12955719 [TBL] [Abstract][Full Text] [Related]
3. Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphisms. Pettigrew C; Wayte N; Lovelock PK; Tavtigian SV; Chenevix-Trench G; Spurdle AB; Brown MA Breast Cancer Res; 2005; 7(6):R929-39. PubMed ID: 16280041 [TBL] [Abstract][Full Text] [Related]
4. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene. Bonnet C; Krieger S; Vezain M; Rousselin A; Tournier I; Martins A; Berthet P; Chevrier A; Dugast C; Layet V; Rossi A; Lidereau R; Frébourg T; Hardouin A; Tosi M J Med Genet; 2008 Jul; 45(7):438-46. PubMed ID: 18424508 [TBL] [Abstract][Full Text] [Related]
6. A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients. Sanz DJ; Acedo A; Infante M; Durán M; Pérez-Cabornero L; Esteban-Cardeñosa E; Lastra E; Pagani F; Miner C; Velasco EA Clin Cancer Res; 2010 Mar; 16(6):1957-67. PubMed ID: 20215541 [TBL] [Abstract][Full Text] [Related]
7. Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programs. Vreeswijk MP; Kraan JN; van der Klift HM; Vink GR; Cornelisse CJ; Wijnen JT; Bakker E; van Asperen CJ; Devilee P Hum Mutat; 2009 Jan; 30(1):107-14. PubMed ID: 18693280 [TBL] [Abstract][Full Text] [Related]
8. Pathological splice mutations outside the invariant AG/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5' end of the BRCA1 gene. Claes K; Vandesompele J; Poppe B; Dahan K; Coene I; De Paepe A; Messiaen L Oncogene; 2002 Jun; 21(26):4171-5. PubMed ID: 12037674 [TBL] [Abstract][Full Text] [Related]
9. Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene. Aretz S; Uhlhaas S; Sun Y; Pagenstecher C; Mangold E; Caspari R; Möslein G; Schulmann K; Propping P; Friedl W Hum Mutat; 2004 Nov; 24(5):370-80. PubMed ID: 15459959 [TBL] [Abstract][Full Text] [Related]
10. Colocalisation of predicted exonic splicing enhancers in BRCA2 with reported sequence variants. Pettigrew CA; Wayte N; Wronski A; Lovelock PK; Spurdle AB; Brown MA Breast Cancer Res Treat; 2008 Jul; 110(2):227-34. PubMed ID: 17899372 [TBL] [Abstract][Full Text] [Related]
11. Detection of germline mutations in the BRCA1 gene by RNA-based sequencing. Jakubowska A; Górski B; Byrski T; Huzarski T; Gronwald J; Menkiszak J; Cybulski C; Debniak T; Hadaczek P; Scott RJ; Lubinski J Hum Mutat; 2001 Aug; 18(2):149-56. PubMed ID: 11462239 [TBL] [Abstract][Full Text] [Related]
12. RNA-based analysis of BRCA1 and BRCA2 gene alterations. Bonatti F; Pepe C; Tancredi M; Lombardi G; Aretini P; Sensi E; Falaschi E; Cipollini G; Bevilacqua G; Caligo MA Cancer Genet Cytogenet; 2006 Oct; 170(2):93-101. PubMed ID: 17011978 [TBL] [Abstract][Full Text] [Related]
13. The effect of disease-associated HRPT2 mutations on splicing. Hahn MA; McDonnell J; Marsh DJ J Endocrinol; 2009 Jun; 201(3):387-96. PubMed ID: 19332451 [TBL] [Abstract][Full Text] [Related]
14. Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression. Chen X; Truong TT; Weaver J; Bove BA; Cattie K; Armstrong BA; Daly MB; Godwin AK Hum Mutat; 2006 May; 27(5):427-35. PubMed ID: 16619214 [TBL] [Abstract][Full Text] [Related]
15. Aberrant splicing induced by missense mutations in BRCA1: clues from a humanized mouse model. Yang Y; Swaminathan S; Martin BK; Sharan SK Hum Mol Genet; 2003 Sep; 12(17):2121-31. PubMed ID: 12915465 [TBL] [Abstract][Full Text] [Related]
16. Complex expression pattern of RPGR reveals a role for purine-rich exonic splicing enhancers. Hong DH; Li T Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3373-82. PubMed ID: 12407146 [TBL] [Abstract][Full Text] [Related]
17. Characterization of functional messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cells. Lu M; Conzen SD; Cole CN; Arrick BA Cancer Res; 1996 Oct; 56(20):4578-81. PubMed ID: 8840964 [TBL] [Abstract][Full Text] [Related]
18. Implications of a novel cryptic splice site in the BRCA1 gene. Hoffman JD; Hallam SE; Venne VL; Lyon E; Ward K Am J Med Genet; 1998 Nov; 80(2):140-4. PubMed ID: 9805131 [TBL] [Abstract][Full Text] [Related]
19. The c.5242C>A BRCA1 missense variant induces exon skipping by increasing splicing repressors binding. Millevoi S; Bernat S; Telly D; Fouque F; Gladieff L; Favre G; Vagner S; Toulas C Breast Cancer Res Treat; 2010 Apr; 120(2):391-9. PubMed ID: 19404736 [TBL] [Abstract][Full Text] [Related]
20. Prediction of single-nucleotide substitutions that result in exon skipping: identification of a splicing silencer in BRCA1 exon 6. Raponi M; Kralovicova J; Copson E; Divina P; Eccles D; Johnson P; Baralle D; Vorechovsky I Hum Mutat; 2011 Apr; 32(4):436-44. PubMed ID: 21309043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]